I added some more shares as well earlier in the month in anticipation of some further interim results and more interest in the company, particularly as a good trial result should accelerate or complete ongoing commercialisation negotiations.
Noted today that another appointment to the board was made with the person having strong biotech commercialisation skills. Is this a statement of confidence in the results of the about to be completed Canadian trial?? Let's hope so.
Good luck to all TIS holders.
TIS Price at posting:
15.8¢ Sentiment: LT Buy Disclosure: Held